Hillhouse Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Hillhouse Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,751,200	Closed	-$220M	–	52
2018 Q3	$220M	Buy	2,751,200 +2,132,809	+345%	+$199M	5.88%	4
2018 Q2	$61.4M	Hold	618,391	–	–	1.05%	21
2018 Q1	$50.1M	Hold	618,391	–	–	0.88%	21
2017 Q4	$48.7M	Hold	618,391	–	–	0.83%	18
2017 Q3	$57.1M	Sell	618,391 -135,233	-18%	-$13M	0.94%	17
2017 Q2	$85.2M	Buy	753,624 +490,874	+187%	+$54.9M	1.31%	14
2017 Q1	$26.3M	Buy	+262,750	New	+$28.1M	0.51%	19

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hillhouse Investment Management's CBPO Position: Q4 2018 in Review

Hillhouse Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 2,751,200 shares — an estimated $220M sold.

Hillhouse Investment Management first reported a position in CBPO in Q1 2017 and held it in 7 quarters. The position peaked at $220M in Q3 2018. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

Hillhouse Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
Hillhouse Investment Management sold 2,751,200 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $220M.
Hillhouse Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 7 quarters.
Hillhouse Investment Management's China Biologic Products Holdings, Inc. position peaked at $220M in Q3 2018.
67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.